Infection site | Number of episodes | Organisms | Median time to development of infection (days) |
---|---|---|---|
Bloodstream infection | 11 | Escherichia coli (4) | 17 (6-28) |
ESBL E. coli (1) | |||
E. coli + Enterococcus faecium (1) | |||
E. faecium (1) | |||
Klebsiella pneumoniae (1) | |||
Staphylococcus aureus (1) | |||
Pseudomonas aeruginosa (2) | |||
Pneumonia | 9 | Culture negative (5) | 7 (4-16) |
Candida glabrata (1) | |||
K. pneumoniae (1) | |||
Organism of the coliform group (1) | |||
Stenotrophomonas maltophilia (1) | |||
Wound infection | 24 | Culture negative (11) | 10 (4-14) |
Bacteroides fragilis (1) | |||
E. coli (4), | |||
ESBL E. coli (1) | |||
Mixed anaerobes (1) | |||
Organism of the coliform group (2) | |||
Organism of the coliform group + E. faecalis (1) | |||
Organism of the coliform group + MRSA (1) | |||
Organism of the coliform group + S. aureus (1) | |||
P. aeruginosa (1) | |||
Urinary tract infection | 15 | Candida albicans (1) | 8 (6-12) |
Culture negative (2) | |||
E. coli (6) | |||
ESBL E. coli (1) | |||
Mixed growth (2) | |||
Organism of the coliform group (2) | |||
P. aeruginosa (1) | |||
Intra-abdominal infection | 17 | Culture negative (6) | 9 (7-14) |
E. coli (2) | |||
E. coli + E. faecium (1) | |||
ESBL E. coli + VRE (1) | |||
E. faecalis (1) | |||
E. faecium + Candida albicans (1) | |||
C. albicans (1) | |||
Enterobacter cloacae (1) | |||
E. cloacae + Organism of the coliform group (1) | |||
E. aerogenes + P. aeruginosa (1) | |||
VRE (1) | |||
Intravascular catheter- related infection | 2 | K. pneumoniae (1) | 15 (3-27) |
Organism of the coliform group (1) | |||
Skin infection | 1 | Varicella zoster virus (VZV) | 30 |